Latest Personalized medicine Stories
SAN FRANCISCO, June 4, 2014 /PRNewswire/ -- MedGenome, the leading provider of genomic diagnostics for oncology in India and a leading provider of oncological bioinformatics to the West, today
NEW YORK, June 3, 2014 /PRNewswire/ -- Exosome Diagnostics, a leading developer of non-invasive, biofluid-based molecular diagnostics, today announced that Vincent J.
Diagnostic insights into gene mutations in solid tumor cancers will aid therapy selection and prognosis for patients and advance research NEW YORK and MADISON, N.J., June
A study of 338 patients with coronary artery disease has identified a gene expression profile associated with an elevated risk of cardiovascular death.
Tissue diagnostics are an important set of techniques, primarily used for the diagnosis, monitoring and management of cancer.
Strand celebrates the largest commercial adoption of genomics in cancer care to date ROCKVILLE, Md., May 28, 2014 /PRNewswire/ -- Strand Genomics Inc.
Emerging biotech firm appoints prominent scientist/inventor as well as distinguished scientists/entrepreneurs to enhance scientific and business capabilities. Fayetteville,
MarketReportsOnline.com adds "Deals in Oncology Personalized Medicine Industry - Worldwide Analysis" report to its research store.
Future of DNA sequencing will shift from a laboratory-based setup to point of care testing in the next 5 years LONDON, May 27, 2014 /PRNewswire/ -- The Western European next-generation
- Large; stout; burly.